Overall, these success show that ketamine should be considered a pharmacologic option for chronic neuropathic pain refractory to plain treatment. Before completion of the primary RCT of repeated ketamine for PTSD, results have been published from two preliminary studies of recurring ketamine treatment among patients with treatment-resistant depression comorbid with https://williamv369yhm9.oblogation.com/profile